Improving Dissolution Rate and Solubility of Palbociclib Salts/Cocrystal for Anticancer Efficacy
Authors:
- Suryanarayana AlluSASuryanarayana Allu
- Ji-Hun AnJAJi-Hun An
- Bum Jun ParkBPBum Jun Park
- Woo-Sik KimWoo-Sik Kim
- 8 February 2024
- journal article
- research article
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1305
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea
This publication has 54 references indexed in Scilit:
- Combination of cyclin-dependent kinase and immune checkpoint inhibitors for the treatment of bladder cancerCancer Immunology, Immunotherapy, 2020
- Pharmaceutical cocrystals, salts and multicomponent systems; intermolecular interactions and property based designAdvanced Drug Delivery Reviews, 2017
- Pharmaceutical aspects of salt and cocrystal forms of APIs and characterization challengesAdvanced Drug Delivery Reviews, 2017
- Recent progress of structural study of polymorphic pharmaceutical drugsAdvanced Drug Delivery Reviews, 2017
- Palbociclib induces activation of AMPK and inhibits hepatocellular carcinoma in a CDK4/6‐independent mannerMolecular Oncology, 2017
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdvanced Drug Delivery Reviews, 2012
- Combined Use of Crystalline Salt Forms and Precipitation Inhibitors to Improve Oral Absorption of Celecoxib from Solid Oral FormulationsJournal of Pharmaceutical Sciences, 2007
- Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution ratesAdvanced Drug Delivery Reviews, 2007
- Salt formation to improve drug solubilityAdvanced Drug Delivery Reviews, 2007
- Supramolecular Synthons in Crystal Engineering—A New Organic SynthesisAngewandte Chemie International Edition, 1995